Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-05-17
1995-09-12
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514394, 548254, 5483044, A61K 31495, A61K 31505, C07D47104, C07D23504
Patent
active
054496829
ABSTRACT:
Substituted heterocycles attached through a methylene bridge to novel substituted phenyl derivatives of the Formula I are useful as angiotensin II antagonists. ##STR1## wherein the substituents are as defined in the claims.
REFERENCES:
patent: 4880804 (1989-11-01), Carini et al.
patent: 5128327 (1992-07-01), Chakravarty et al.
patent: 5151435 (1992-09-01), Bagley et al.
patent: 5162325 (1992-11-01), Chakravarty et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5177095 (1993-01-01), Greenlee et al.
patent: 5183810 (1993-02-01), Greenlee et al.
patent: 5198438 (1993-03-01), Allen et al.
patent: 5236928 (1993-08-01), Chakravarty et al.
patent: 5252574 (1993-10-01), Allen et al.
patent: 5264439 (1993-11-01), Greenlee et al.
Dhanoa Daljit S.
Fitch Kenneth J.
Greenlee William J.
Hangauer David
Patchett Arthur A.
Camara Valerie J.
Daniel Mark R.
DiPrima Joseph F.
Grumbling Matthew V.
Merck & Co. , Inc.
LandOfFree
Angiotensin II antagonists incorporating a substituted benzyl el does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II antagonists incorporating a substituted benzyl el, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II antagonists incorporating a substituted benzyl el will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-405516